logo
QuidelOrtho (NASDAQ:QDEL) Reports Q1 In Line With Expectations, Stock Soars

QuidelOrtho (NASDAQ:QDEL) Reports Q1 In Line With Expectations, Stock Soars

Yahoo08-05-2025
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) met Wall Street's revenue expectations in Q1 CY2025, but sales fell by 2.6% year on year to $692.8 million. The company's outlook for the full year was close to analysts' estimates with revenue guided to $2.71 billion at the midpoint. Its non-GAAP profit of $0.74 per share was 25% above analysts' consensus estimates.
Is now the time to buy QuidelOrtho? Find out in our full research report.
QuidelOrtho (QDEL) Q1 CY2025 Highlights:
Revenue: $692.8 million vs analyst estimates of $689.8 million (2.6% year-on-year decline, in line)
Adjusted EPS: $0.74 vs analyst estimates of $0.59 (25% beat)
Adjusted EBITDA: $159.8 million vs analyst estimates of $149.4 million (23.1% margin, 7% beat)
The company reconfirmed its revenue guidance for the full year of $2.71 billion at the midpoint
Management reiterated its full-year Adjusted EPS guidance of $2.32 at the midpoint
EBITDA guidance for the full year is $595 million at the midpoint, in line with analyst expectations
Operating Margin: 4.7%, up from -247% in the same quarter last year
Constant Currency Revenue fell 1.1% year on year (-15.5% in the same quarter last year)
Market Capitalization: $1.75 billion
'We delivered solid first quarter performance driven by growth in our Labs business and the strength of our recurring revenue business model,' said Brian J. Blaser, President and Chief Executive Officer, QuidelOrtho.
Company Overview
Born from the 2022 merger of Quidel and Ortho Clinical Diagnostics, QuidelOrtho (NASDAQ:QDEL) develops and manufactures diagnostic testing solutions for healthcare providers, from rapid point-of-care tests to complex laboratory instruments and systems.
Sales Growth
Examining a company's long-term performance can provide clues about its quality. Any business can have short-term success, but a top-tier one grows for years. Luckily, QuidelOrtho's sales grew at an excellent 23.3% compounded annual growth rate over the last five years. Its growth beat the average healthcare company and shows its offerings resonate with customers.
QuidelOrtho Quarterly Revenue
We at StockStory place the most emphasis on long-term growth, but within healthcare, a half-decade historical view may miss recent innovations or disruptive industry trends. QuidelOrtho's recent performance marks a sharp pivot from its five-year trend as its revenue has shown annualized declines of 5.7% over the last two years.
QuidelOrtho Year-On-Year Revenue Growth
We can better understand the company's sales dynamics by analyzing its constant currency revenue, which excludes currency movements that are outside their control and not indicative of demand. Over the last two years, its constant currency sales averaged 8.9% year-on-year declines. Because this number is lower than its normal revenue growth, we can see that foreign exchange rates have boosted QuidelOrtho's performance.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Piper Sandler Reduces PT on lululemon athletica (LULU) Stock
Piper Sandler Reduces PT on lululemon athletica (LULU) Stock

Yahoo

time28 minutes ago

  • Yahoo

Piper Sandler Reduces PT on lululemon athletica (LULU) Stock

lululemon athletica inc. (NASDAQ:LULU) is one of the Reddit Stocks with the Highest Upside Potential. On July 29, Piper Sandler reduced the price target on the company's stock to $200 from $270, while keeping a 'Neutral' rating, as reported by The Fly. As per the firm, the fall in lululemon athletica inc. (NASDAQ:LULU)'s shares this year was because of a correction in the multiple. In Q1 2025, the company achieved growth throughout its channels, categories, and markets, including the US, demonstrating the continued strength and agility of its business model. A store employee in an athletic apparel store restocking merchandise. Amidst the dynamic macro environment, lululemon athletica inc. (NASDAQ:LULU) plans to leverage its robust financial position and competitive advantages to play offense, while it continues to invest in growth opportunities. In Q1 2025, its net revenue rose 7% to $2.4 billion, or 8% on a constant dollar basis, with the Americas net revenue rising 3% and the International net revenue increasing 19%. For Q2 2025, lululemon athletica inc. (NASDAQ:LULU) anticipates net revenue of between $2.535 billion – $2.560 billion, reflecting growth of 7% – 8%. RGA Investment Advisors, an investment management company, released its Q1 2025 investor letter. Here is what the fund said: 'Late in the quarter, we purchased shares in Lululemon athletica inc. (NASDAQ:LULU), despite uncertainty about the tariff situation. Many of you are familiar with the brand. Lulu is a leading athleisure brand and though competition has increased from upstart offerings like Vuori, Alo and Fabletics, the company has continued to maintain relevance and perform admirably. These upstarts have varied approaches, but in aggregate, they have won share with a combination of faster, more tasteful fashion and cheaper prices. Importantly, this share has predominantly come from Nike–the 10,000 pound gorilla of the industry that continues to see negative topline growth. Even within the competitive landscape, it is notable that Vuori and Alo enthusiasts still consider Lulu core to their wardrobe, given the demonstrable quality advantage of the company's proprietary fabrics. Although Lulu has benefited from dominance in fashion, its core calling has been performance and that segment of the market remains unquestioned. While we acknowledge the potential of LULU as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio

Amazon (AMZN) Expands Same-Day Grocery Delivery, Escalating Retail Delivery Battle
Amazon (AMZN) Expands Same-Day Grocery Delivery, Escalating Retail Delivery Battle

Yahoo

time28 minutes ago

  • Yahoo

Amazon (AMZN) Expands Same-Day Grocery Delivery, Escalating Retail Delivery Battle

Inc. (NASDAQ:AMZN) is one of the best growth stocks to buy according to analysts. Inc. (NASDAQ:AMZN) announced on August 13 that it will be expanding its same-day delivery service to include fresh and frozen grocery items for its Prime members. The company did not reveal the cities included in the rollout. Ken Wolter / Starting this week, Prime subscribers in select cities will be able to receive items such as strawberries, milk, meats, and frozen dinners within hours of placing an order. This will intensify competition for same-day deliveries for perishable items, with other retail giants like Walmart. What is likely to work in the e-commerce giant's favor is its improving logistics and Whole Foods' infrastructure. Same-day grocery delivery is a massive battleground in e-commerce, with customers spoiled for choice and expecting faster delivery. The tech behemoth has already been offering grocery delivery through its Amazon Fresh and Whole Foods platforms. However, the latest move indicates a deeper commitment by the company to improve its share in the perishable item segment. If the company can capture a share of the same-day delivery for perishable items and scale up, its impact in the grocery sector is likely to grow; it is likely to put pressure on the traditional grocers and delivery rivals, given Amazon's scale and delivery moat. While we acknowledge the potential of AMZN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Strategy Incorporated (MSTR) Announces Q2 2025 Results
Strategy Incorporated (MSTR) Announces Q2 2025 Results

Yahoo

time28 minutes ago

  • Yahoo

Strategy Incorporated (MSTR) Announces Q2 2025 Results

MicroStrategy Incorporated, doing business as, Strategy Incorporated (NASDAQ:MSTR) is one of the Reddit Stocks with the Highest Upside Potential. On July 31, the company announced its Q2 2025 results, with net income coming at $10.0 billion. In Q2 2025 and into July, Strategy Incorporated (NASDAQ:MSTR) delivered another period of strong execution and growth. The company expanded its bitcoin holdings to 628,791 bitcoins, garnered more than $10 billion via its ATM programs and IPOs, and witnessed increased institutional and retail demand for the securities. A software engineer wearing a headset, collaborating with a remote team on a project. Strategy Incorporated (NASDAQ:MSTR)'s operating income for Q2 2025 came in at ~$14.03 billion, a 7,106.4% increase YoY. Operating income consisted of an unrealized gain on the company's digital assets, which amounted to $14.0 billion. Through July 29, the company's Bitcoin holdings make up for 3% of all the Bitcoin ever to be in existence. This places the company as the most dominant player in the Bitcoin Treasury Company space. Strategy Incorporated (NASDAQ:MSTR) raised an impressive $18.3 billion in capital YTD, accounting for 81% of the total capital it raised in all of last year combined. Greenlight Capital, an investment management firm, released its Q4 2024 investor letter. Here is what the fund said: 'There is an open debate as to whether Bitcoin will at some point enter the mainstream as an official currency. In fact, there is a bill before Congress for the U.S. to establish a 'Strategic Bitcoin Reserve' and buy one million Bitcoins over five years. The bill's purpose appears to be the use of public funds to ramp up the price of Bitcoin, thereby enhancing the wealth of existing Bitcoin holders. This seems a dubious use of taxpayer funds, but the new administration has a lot of Bitcoin-owning supporters, so it might happen. More likely, cooler heads will decide that the government should not borrow another trillion dollars in the bond market to speculate in Bitcoin and that there is, in fact, nothing strategic about doing so. While we acknowledge the potential of MSTR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now Disclosure: None. This article is originally published at Insider Monkey.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store